Cantor Fitzgerald Reiterates “Overweight” Rating for DocGo (NASDAQ:DCGO)

DocGo (NASDAQ:DCGO)‘s stock had its “overweight” rating restated by research analysts at Cantor Fitzgerald in a research report issued on Tuesday,Benzinga reports. They presently have a $3.00 price target on the stock. Cantor Fitzgerald’s target price points to a potential upside of 295.26% from the stock’s current price.

Several other brokerages have also recently weighed in on DCGO. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DocGo in a research note on Monday, December 29th. Needham & Company LLC restated a “buy” rating and issued a $3.00 target price on shares of DocGo in a report on Tuesday. Two investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $2.50.

DocGo Trading Up 17.2%

DCGO opened at $0.76 on Tuesday. The company has a fifty day simple moving average of $0.77 and a 200 day simple moving average of $1.03. The firm has a market cap of $74.24 million, a price-to-earnings ratio of -1.43 and a beta of 0.95. DocGo has a twelve month low of $0.60 and a twelve month high of $2.88.

Institutional Investors Weigh In On DocGo

A number of hedge funds have recently bought and sold shares of DCGO. P.A.W. Capital Corp increased its stake in shares of DocGo by 60.0% in the second quarter. P.A.W. Capital Corp now owns 3,200,000 shares of the company’s stock worth $5,024,000 after purchasing an additional 1,200,000 shares during the period. Geode Capital Management LLC grew its position in DocGo by 3.4% during the fourth quarter. Geode Capital Management LLC now owns 2,259,901 shares of the company’s stock worth $1,984,000 after buying an additional 73,900 shares in the last quarter. Jefferies Financial Group Inc. increased its stake in DocGo by 5.7% during the second quarter. Jefferies Financial Group Inc. now owns 2,144,456 shares of the company’s stock valued at $3,367,000 after acquiring an additional 115,000 shares during the period. State Street Corp lifted its position in shares of DocGo by 2.0% in the 4th quarter. State Street Corp now owns 1,969,603 shares of the company’s stock worth $1,729,000 after acquiring an additional 39,125 shares during the period. Finally, Isthmus Partners LLC boosted its position in shares of DocGo by 13.8% during the 4th quarter. Isthmus Partners LLC now owns 888,845 shares of the company’s stock valued at $780,000 after acquiring an additional 107,592 shares in the last quarter. 56.44% of the stock is currently owned by institutional investors.

Key DocGo News

Here are the key news stories impacting DocGo this week:

• Positive Sentiment: Management set 2026 revenue guidance of $290M–$310M and reiterated a push toward profitability while saying it is exploring strategic alternatives — a forward-looking plan that can support valuation if execution and margin improvement follow. DocGo outlines 2026 revenue guidance of $290M–$310M as company targets profitability and explores strategic alternatives
• Positive Sentiment: Q4 revenue beat consensus and management raised near-term outlook, which triggered an initial strong intraday rally (reports noted a ~15% jump after results). This revenue upside supports the company’s growth story despite other headwinds. DocGo shares surge 15% on Q4 revenue beat and raised guidance
• Neutral Sentiment: Full Q4 earnings call transcript is available — management provided color on the revenue beat, profitability timeline, and the rationale behind strategic-alternatives exploration; investors should read the transcript for details on cadence and capital allocation. DocGo Inc. (DCGO) Q4 2025 Earnings Call Transcript
• Negative Sentiment: Despite the revenue beat, EPS missed badly — the company reported a sizable per-share loss that was well below estimates, which is keeping investor focus on profitability execution and potential dilution. DocGo Inc. (DCGO) Reports Q4 Loss, Beats Revenue Estimates
• Negative Sentiment: Reported revenue was down year-over-year due to the wind-down of the MIG business, and profitability metrics remain negative (net margin and ROE). Those structural headwinds help explain why some of the initial rally faded as investors dig into the quality of revenue and near-term cash flow. DocGo Announces Fourth Quarter and Full Year 2025 Results

DocGo Company Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.